tiprankstipranks
RayzeBio, Inc. (RYZB)
NASDAQ:RYZB
US Market

RayzeBio, Inc. (RYZB) Income Statement

27 Followers

RayzeBio, Inc. Income Statement

Last quarter (Q3 2023), RayzeBio, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q3, RayzeBio, Inc.'s net income was $-19.40M. See RayzeBio, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21
Total Revenue
---
Cost of Revenue
---
Gross Profit
---
Operating Expense
$ 21.68M$ 72.12M$ 39.40M
Operating Income
$ -21.68M$ -72.12M$ -39.40M
Net Non Operating Interest Income Expense
$ 3.49M$ 3.52M$ 265.00K
Other Income Expense
$ 1.21M$ 4.55M$ 17.45M
Pretax Income
$ -19.40M$ -73.15M$ -56.58M
Tax Provision
---
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -19.40M$ -73.15M$ -56.58M
Basic EPS
$ -1.26$ -0.02$ -0.02
Diluted EPS
$ -1.26$ -0.02$ -0.02
Basic Average Shares
$ 15.40M$ 3.68M$ 2.69M
Diluted Average Shares
$ 15.40M$ 3.68M$ 2.69M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 21.68M$ 72.12M$ 39.40M
Net Income From Continuing And Discontinued Operation
$ -19.40M$ -73.15M$ -56.58M
Normalized Income
---
Interest Expense
---
EBIT
---
EBITDA
---
Currency in USD

RayzeBio, Inc. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis